Incidence and risk factors for psoriasis in the general population.
about
Anti-TNF agents for paediatric psoriasisOral fumaric acid esters for psoriasisIndoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasisOral fumaric acid esters for psoriasisTopical treatments for scalp psoriasisAnti-TNF agents for paediatric psoriasisSystemic Treatment of Pediatric Psoriasis: A ReviewRelationships between Adipose Tissue and Psoriasis, with or without ArthritisA systematic review of worldwide epidemiology of psoriasis.Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis.Lack of association of high body mass index with risk for developing polymyalgia rheumatica.Narrowband ultraviolet B light treatment changes plasma concentrations of MMP-3, MMP-9 and TIMP-3 in psoriatic patients.Validity of diagnostic coding within the General Practice Research Database: a systematic reviewThe risk of stroke in patients with psoriasisPsoriasis and hypertension severity: results from a case-control study.Diet and weight loss as a treatment for psoriasis.Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.Obesity, waist circumference, weight change and the risk of psoriasis in US women.Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.The validity of the diagnostic code for hidradenitis suppurativa in an electronic databaseTrends in incidence of adult-onset psoriasis over three decades: a population-based study.Validity of The Health Improvement Network (THIN) for the study of psoriasis.Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort studyNutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet?Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences.Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literatureThe association of psoriasis and elevated blood lipids in overweight and obese children.Cardiovascular comorbiditiy in psoriasisInterplay between innate and adaptive immunity in the development of non-infectious uveitisSmoking and risk of incident psoriasis among women and men in the United States: a combined analysis.Association between Psoriasis Vulgaris and Coronary Heart Disease in a Hospital-Based Population in Japan.The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European CountriesThe Epidemiology of Psoriatic Arthritis.Prevalence of psoriasis among adults in the U.S.: 2003-2006 and 2009-2010 National Health and Nutrition Examination Surveys.The association between smoking and the prevalence of metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years.Risk and predictors of cardiovascular disease in psoriasis: a population-based study.Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009.Psoriasis and metabolic disease: epidemiology and pathophysiologyRates of Cancers and Opportunistic Infections in Patients With Psoriatic Arthritis Compared With Patients Without Psoriatic Arthritis.
P2860
Q24187673-29654D8F-F8C5-4E8E-8A2F-AB7E31AEE7F4Q24187957-BF852E6B-5F0D-4A7C-B376-30124769CFD3Q24188256-8E3B7EF8-E975-4C6A-935E-D85198B8F0B1Q24198185-CE300C06-303C-46EE-9164-8CADE2820112Q24200746-804359C6-D208-4D59-9039-975B92DBB6FDQ24201907-B3321C7D-E997-488C-A0CF-76A783633E6CQ26753026-1C39E06F-4CFC-4886-8519-9D558CC7950EQ27025534-49267978-BF7B-4E9D-B4AB-6C2EFF7A2560Q30248242-00D14352-69B2-4612-AE05-7640F5A7244CQ30369467-D90238BC-C085-4C27-BE89-92DCC53F3081Q33574671-9BD35BD0-79B1-4C1E-BC03-1E5A96CA311BQ33575341-91AE00BC-9CF2-49EB-ACA1-C6854C9F0EEFQ33631646-FDE32FFB-645C-4B96-9342-124DF9A7F911Q33689383-BC66D934-1395-48CA-934E-66B6B258F2B5Q33831094-F5DB0E5C-6302-4869-B445-C6DF613BD235Q33867611-4BB874A6-0C3E-4DB5-B1F0-0AE6839243E2Q33940511-275BF52A-DDE0-47DB-BAD7-D2436FE753CDQ34253312-217C67DF-5988-4FCF-BDE1-E13FFB8222A1Q34266151-C8E5FB52-0C5B-4F55-93CC-169DC0FE591CQ34449302-11BDAFC4-B546-4543-A653-271DF29E9906Q34451023-BD725D1B-271E-41C7-B3F4-FCF874EF4004Q34527982-896C819B-2B46-4741-8E12-CD1E04900914Q34721703-9BC4AC2C-D9C7-4D15-B3BF-E980C48447B8Q34956195-73E6CD73-5BEA-4DD2-BC81-06139D99818BQ35047630-7844CB70-F52B-4082-9277-785BEFBFE2D8Q35115207-10CEEC8B-8D09-44AC-89ED-50900412C2EEQ35168945-AD678228-65CA-4F95-B49A-9250D667CE99Q35199755-6623CB63-84C5-45A4-9A07-A203F1D14F75Q35564655-1DF5469C-025A-4B8B-81DC-4680C559CAD2Q35784059-0F153E19-3256-4A21-8418-019A3BD472CFQ35896544-E24AFCBF-C269-42EF-82DD-44DF918F1861Q35934076-1C2A746E-E37F-41BD-9023-2A897F48A5F5Q36059239-2B6882B1-B409-4030-BF8C-5AC31D7D286CQ36175115-057D11A3-FBA0-4F75-9C51-780AF12E1BB1Q36299948-A84E4BF6-8494-41B8-A95F-A22DB069AAFAQ36408491-30F382F8-1BCF-4FDF-AAA6-82B860209E73Q36515160-FC54FDCE-EA02-4244-BC78-5CA116293E61Q37038847-482A5E2E-1025-415D-9366-99010E7DBA7FQ37102789-6F2FF70E-61D6-403E-BF2E-EE75AB06CEF7Q37139101-CE219FB3-9F81-4DCE-806D-8EF11E6FF737
P2860
Incidence and risk factors for psoriasis in the general population.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Incidence and risk factors for psoriasis in the general population.
@en
type
label
Incidence and risk factors for psoriasis in the general population.
@en
prefLabel
Incidence and risk factors for psoriasis in the general population.
@en
P2093
P1433
P1476
Incidence and risk factors for psoriasis in the general population.
@en
P2093
Consuelo Huerta
Elena Rivero
Luis A García Rodríguez
P304
P356
10.1001/ARCHDERM.143.12.1559
P577
2007-12-01T00:00:00Z